| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
58,625,000 |
| Market
Cap: |
1.76(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.72 - $37.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
98,505 |
119,208 |
124,343 |
450,780 |
| Total Sell Value |
$3,345,846 |
$3,929,526 |
$4,091,741 |
$15,155,681 |
| Total People Sold |
1 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
10 |
11 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
AS |
$39.92 |
$192,638 |
D/D |
(4,826) |
1,644 |
|
-16% |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
OE |
$9.13 |
$44,061 |
D/D |
4,826 |
6,470 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2023-01-17 |
4 |
AS |
$40.03 |
$1,018,728 |
D/D |
(25,446) |
791,173 |
|
-16% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2023-01-17 |
4 |
OE |
$9.56 |
$400,755 |
D/D |
41,920 |
816,619 |
|
- |
|
| Hudson Frederick M. |
Director |
– • – |
2023-01-10 |
4 |
OE |
$7.90 |
$68,904 |
D/D |
8,722 |
30,985 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2023-01-06 |
4 |
AS |
$39.90 |
$6,943 |
D/D |
(174) |
1,644 |
|
-11% |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2023-01-06 |
4 |
OE |
$9.13 |
$1,589 |
D/D |
174 |
1,818 |
|
- |
|
| Newhall Charles W III |
Director |
– • – |
2022-12-28 |
4 |
OE |
$7.90 |
$68,904 |
D/D |
8,722 |
110,453 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-12-21 |
4 |
AS |
$38.14 |
$433,070 |
D/D |
(11,354) |
814,699 |
|
-2% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-12-21 |
4 |
OE |
$9.56 |
$176,592 |
D/D |
18,472 |
826,053 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
807,581 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-12-20 |
4 |
AS |
$38.02 |
$152,317 |
D/D |
(4,006) |
791,956 |
|
-0% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-12-20 |
4 |
OE |
$9.56 |
$62,408 |
D/D |
6,528 |
795,962 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-12-01 |
4 |
AS |
$37.48 |
$187,416 |
D/D |
(5,000) |
1,644 |
|
-0% |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-12-01 |
4 |
OE |
$9.13 |
$45,650 |
D/D |
5,000 |
6,644 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-25 |
4 |
AS |
$35.18 |
$391,685 |
D/D |
(11,135) |
789,434 |
|
5% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-25 |
4 |
OE |
$9.56 |
$170,111 |
D/D |
17,794 |
800,569 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-23 |
4 |
AS |
$35.05 |
$79,189 |
D/D |
(2,259) |
782,775 |
|
3% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-23 |
4 |
OE |
$9.56 |
$34,569 |
D/D |
3,616 |
785,034 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-22 |
4 |
AS |
$35.00 |
$21,001 |
D/D |
(600) |
781,418 |
|
3% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-22 |
4 |
OE |
$9.56 |
$9,168 |
D/D |
959 |
782,018 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-21 |
4 |
AS |
$35.01 |
$18,592 |
D/D |
(531) |
781,059 |
|
3% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-21 |
4 |
OE |
$9.56 |
$8,107 |
D/D |
848 |
781,590 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-15 |
4 |
AS |
$35.00 |
$39,028 |
D/D |
(1,115) |
780,742 |
|
6% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-11-15 |
4 |
OE |
$9.56 |
$17,045 |
D/D |
1,783 |
781,857 |
|
- |
|
345 Records found
|
|
Page 5 of 14 |
|
|
0.76 (2.59%) 
